Print

CancerVax Corporation (CNVX) Stockholders Approve Merger With Micromet  
5/4/2006 12:10:43 PM

CancerVax Corporation (NASDAQ: CNVX), a biotechnology company focused on the research, development and commercialization of novel biological products for the treatment of cancer, announced today that its stockholders approved the previously announced merger with Micromet AG at its annual stockholders meeting held on May 3, 2006. The transaction, which is subject to customary closing conditions, is expected to close on or about May 5, 2006.
//-->